adenosine diphosphate has been researched along with symmetric dimethylarginine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chan, WP; Heresztyn, T; Horowitz, JD; Liberts, EA; Marber, MS; Norman, RJ; Rajendran, S; Saha, M; Willoughby, SR | 1 |
Doroszko, A; Fortuna, P; Gajecki, D; Gawryś, J; Gawryś, K; Leśniewska, J; Majda, F; Mlynarz, P; Szahidewicz-Krupska, E; Wiśniewski, J | 1 |
Dizdarevic, AM; Eyileten, C; Gasecka, A; Jarosz-Popek, J; Lang, IM; Nowak, A; Postula, M; Siller-Matula, JM; Ufnal, M; Wolska, M | 1 |
3 other study(ies) available for adenosine diphosphate and symmetric dimethylarginine
Article | Year |
---|---|
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
Topics: Adenosine Diphosphate; Adult; Albuterol; Arginine; Body Composition; C-Reactive Protein; Cohort Studies; Endothelial Cells; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Malondialdehyde; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Obesity; Oxidative Stress; Platelet Aggregation; Platelet Function Tests; Polycystic Ovary Syndrome; Stem Cells; Time Factors; Vasodilator Agents | 2009 |
Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus.
Topics: Adenosine Diphosphate; Adult; Aged; Arginine; Blood Platelets; Calcium; Case-Control Studies; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Female; Humans; Male; Mass Spectrometry; Middle Aged; Nitric Oxide; Platelet Activation; Platelet Aggregation; Risk Factors | 2020 |
High concentration of symmetric dimethylarginine is associated with low platelet reactivity and increased bleeding risk in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Arginine; Biomarkers; Female; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors | 2022 |